Welcome!

Video Authors: Elizabeth White, Yakov Fain, Liz McMillan, Dan Ristic, Jnan Dash

News Feed Item

MDA Names Dr. Grace Pavlath to Head Scientific Program as Research Department Intensifies Focus on Ushering Treatments Through Drug Pipeline

CHICAGO, Sept. 25, 2014 /PRNewswire-USNewswire/ -- Dr. Grace Pavlath, an accomplished muscle disease researcher and tenured professor in the Department of Pharmacology at the Emory University School of Medicine, has been named as MDA Senior Vice President – Scientific Program Director. Beginning October 31, Dr. Pavlath will become a key member of MDA's Mission Leadership Team and will be responsible for overall management and further development of MDA's scientific program focused on delivering effective therapies for more than 40 neuromuscular diseases and ALS.

MDA logo

"For almost 30 years, Dr. Pavlath has established herself as a leading researcher in cellular and molecular mechanisms that are critical for muscle growth and repair," said Executive Vice President and Chief Medical and Scientific Officer Valerie Cwik, M.D., who will work closely with Pavlath in maintaining the results-driven focus of MDA's program. "She brings a profound understanding and insider's knowledge to today's research landscape and will play a critical role in further leveraging MDA's clinic infrastructure and research programs while working collaboratively with industry stakeholders." 

"Dr. Pavlath's breadth of experience including her deep immersion in neuromuscular research, teaching, mentorship and international scientific leadership roles will serve MDA well as we strengthen our vital commitment to therapy development, which is so critical to MDA's mission to save and improve lives of people fighting muscle disease," said MDA President and CEO Steven M. Derks. "We're thrilled to have someone with Grace's skills join our fight. This is a pivotal time in our history, when we are poised on the brink of new discoveries. Some of our MDA-funded researchers who've been working in the field for decades are so encouraged by the progress being made and the clinical trials underway that they tell us they feel more hopeful than at any other time in their careers."

MDA has redoubled its urgency and commitment to its research program, having adopted strategies that demand a more intentional and proactive perspective on the grant proposal process, with new goals and measurables embedded within the program. MDA plans to direct a greater percentage of its research budget to therapy development. Furthermore, MDA will endeavor to identify key areas to invest research dollars and help identify any gaps in therapy development strategy while proactively requesting grant proposals to fill in those gaps.

"We want more drugs moving through the development pipeline," said Cwik. "The goal is to get them out of the laboratory, through FDA approval and ultimately to individuals affected." MDA is seeking to double the number of drugs being funding annually through its translational research program.

"I am thrilled and honored to join MDA at a time when we are identifying strategies to overturn obstacles in therapy development, actively seeking to accelerate progress for the sake of the children and adults MDA serves," said Pavlath. "I look forward to strengthening my relationships with members of the neuromuscular disease community, so that together we can assess research needs and scientific opportunities that will accelerate and meet MDA's mission objectives."

As MDA's scientific program leader, Pavlath will be based in Atlanta and will provide leadership for MDA through interactions with federal agencies, international neuromuscular disease partners, drug development groups and pharmaceutical companies, as well as with patient advocacy groups and other neuromuscular disease stakeholders while meeting the organization's core standards of excellence. She will also represent MDA at national and international neuromuscular scientific meetings and as an advocate on Capitol Hill in behalf of the families served by MDA.

Pavlath, a graduate of the University of California, Berkeley, received her Ph.D. in Pharmacology from Stanford University and did postdoctoral training at Stanford University and the University of Arizona. She joined Emory University in 1994 as an assistant professor. She is currently a professor in the Department of Pharmacology at Emory.

Pavlath's scientific work has been widely published in peer review journals, and she is the recipient of numerous research grants from the National Institutes of Health, American Heart Association, Emory University, as well as the Muscular Dystrophy Association. She has served and currently serves on numerous national, international and institutional committee memberships, and has organized and chaired several conferences with the focus ranging from skeletal muscle and stem cells to muscle development, function and repair. She has also been a member of the MDA Scientific Advisory Committee since 2008.

About MDA
The Muscular Dystrophy Association is the world's leading nonprofit health agency dedicated to saving and improving the lives of people with muscle disease, including muscular dystrophy, amyotrophic lateral sclerosis (ALS) and other neuromuscular diseases. It does so by funding worldwide research to find treatments and cures; by providing comprehensive health care services and support to MDA families nationwide; and by rallying communities to fight back through advocacy, fundraising and local engagement.

Visit mda.org and follow us at facebook.com/MDAnational and @MDAnews. Learn more about MDA's mission by watching this video.

Logo - http://photos.prnewswire.com/prnh/20120424/DC93207LOGO

SOURCE Muscular Dystrophy Association

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

IoT & Smart Cities Stories
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
SYS-CON Events announced today that CrowdReviews.com has been named “Media Sponsor” of SYS-CON's 22nd International Cloud Expo, which will take place on June 5–7, 2018, at the Javits Center in New York City, NY. CrowdReviews.com is a transparent online platform for determining which products and services are the best based on the opinion of the crowd. The crowd consists of Internet users that have experienced products and services first-hand and have an interest in letting other potential buye...
Founded in 2000, Chetu Inc. is a global provider of customized software development solutions and IT staff augmentation services for software technology providers. By providing clients with unparalleled niche technology expertise and industry experience, Chetu has become the premiere long-term, back-end software development partner for start-ups, SMBs, and Fortune 500 companies. Chetu is headquartered in Plantation, Florida, with thirteen offices throughout the U.S. and abroad.
The standardization of container runtimes and images has sparked the creation of an almost overwhelming number of new open source projects that build on and otherwise work with these specifications. Of course, there's Kubernetes, which orchestrates and manages collections of containers. It was one of the first and best-known examples of projects that make containers truly useful for production use. However, more recently, the container ecosystem has truly exploded. A service mesh like Istio addr...
SYS-CON Events announced today that DatacenterDynamics has been named “Media Sponsor” of SYS-CON's 18th International Cloud Expo, which will take place on June 7–9, 2016, at the Javits Center in New York City, NY. DatacenterDynamics is a brand of DCD Group, a global B2B media and publishing company that develops products to help senior professionals in the world's most ICT dependent organizations make risk-based infrastructure and capacity decisions.
Nicolas Fierro is CEO of MIMIR Blockchain Solutions. He is a programmer, technologist, and operations dev who has worked with Ethereum and blockchain since 2014. His knowledge in blockchain dates to when he performed dev ops services to the Ethereum Foundation as one the privileged few developers to work with the original core team in Switzerland.
Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive...
Headquartered in Plainsboro, NJ, Synametrics Technologies has provided IT professionals and computer systems developers since 1997. Based on the success of their initial product offerings (WinSQL and DeltaCopy), the company continues to create and hone innovative products that help its customers get more from their computer applications, databases and infrastructure. To date, over one million users around the world have chosen Synametrics solutions to help power their accelerated business or per...
DXWorldEXPO LLC announced today that ICOHOLDER named "Media Sponsor" of Miami Blockchain Event by FinTechEXPO. ICOHOLDER gives detailed information and help the community to invest in the trusty projects. Miami Blockchain Event by FinTechEXPO has opened its Call for Papers. The two-day event will present 20 top Blockchain experts. All speaking inquiries which covers the following information can be submitted by email to [email protected] Miami Blockchain Event by FinTechEXPOalso offers sp...
Digital Transformation is much more than a buzzword. The radical shift to digital mechanisms for almost every process is evident across all industries and verticals. This is often especially true in financial services, where the legacy environment is many times unable to keep up with the rapidly shifting demands of the consumer. The constant pressure to provide complete, omnichannel delivery of customer-facing solutions to meet both regulatory and customer demands is putting enormous pressure on...